Treatment of rheumatoid arthritis and related diseases
CA 1085731 A · Owner: Simoons, John R.A. · Inventors: Wyburn-Mason, Roger
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent or these diseases. It has been discovered that clotrimazole bis-phenyl,(2-chlorphenyl)-1-imidazolyl-methane and related compounds, antimycotic drugs with anti-protozoal activity are effective, for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 16, 1980. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 16, 1997.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.